Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 42, 3978-3986, October 1, 1982]
© 1982 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Roth, J. A.
Right arrow Articles by Wesley, R. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Roth, J. A.
Right arrow Articles by Wesley, R. A.

Human Tumor-associated Antigens Detected by Serological Techniques: Analysis of Autologous Humoral Immune Responses to Primary and Metastatic Human Sarcomas by an Enzyme-linked Immunoabsorbant Solid-Phase Assay (ELISA)

Jack A. Roth and Robert A. Wesley

Surgery Branch [J. A. R.] and Biometric Research Branch [R. A. W.], Division of Cancer Treatment, National Cancer Institute, NIH, Bethesda, Maryland 20205

An enzyme-linked immunoabsorbant solid-phase assay was developed for measuring humoral immune responses to human sarcoma-associated antigens, and binding of autologous sera to 1-butanol extracts of fresh sarcomas was determined. Binding of autologous sarcoma patients' sera was reproducible and significantly greater than normal sera. Extensive quantitative competitive binding inhibition tests with normal tissue were unable to completely remove binding to autologous tumor extracts by sera from five of eight patients, thus demonstrating a quantitatively distinct specificity present on tumor tissue. An antibody in autologous sera recognizing a determinant on normal adult tissue was also identified. Autologous humoral immune responses to soluble 1-butanol extracts of paired primary and metastatic human sarcomas from six patients from this group were assessed. Antibody binding was observed to both primary and metastatic tumor extracts; however, binding was significantly greater to the primary extracts in 14 of 16 autologous serum-tumor combinations tested. Absorption and competitive binding inhibition studies demonstrated the presence of common sarcoma-associated antigens in extracts of both the primary tumor and its metastasis from all patients studied. Two individual metastases frmo the same patient also possessed antigens recognized in that patient's primary tumor extract in two cases. Autologous sarcoma patients' sera recognize sarcoma-associated antigens common to both the primary tumor and its metastasis.

Received 1/ 4/82. Accepted 7/ 2/82.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1982 by the American Association for Cancer Research.